Paige Prostate was granted de novo marketing authorization from the FDA to aid in the primary diagnosis of prostate cancer. NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today announced...

The startup's software analyzes tissue-sample images Artificial intelligence was not on Leo Grady's mind when he was applying for college in the early 1990s. The IEEE member was interested in human interaction, linguistics, and psychology,...

To help build out its own portfolio of artificial-intelligence-driven pathology tests, Quest Diagnostics has enlisted the help of Paige to develop a suite of products aimed at individual clinical oncologists as well as larger biopharma...

Company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment   NEW YORK, July 13, 2020 – Paige, a global leader in computational pathology, today announced it received...

Article Published in Nature Medicine Provides Further Scientific Evidence for Deployment of Computational Decision Support Systems to Improve Patient Care NEW YORK, July 15, 2019 – Paige, the leader in computational pathology focused on...